1. Home
  2. LHSW vs LUNG Comparison

LHSW vs LUNG Comparison

Compare LHSW & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LHSW
  • LUNG
  • Stock Information
  • Founded
  • LHSW 2007
  • LUNG 1995
  • Country
  • LHSW China
  • LUNG United States
  • Employees
  • LHSW N/A
  • LUNG N/A
  • Industry
  • LHSW
  • LUNG Industrial Specialties
  • Sector
  • LHSW
  • LUNG Health Care
  • Exchange
  • LHSW NYSE
  • LUNG Nasdaq
  • Market Cap
  • LHSW 101.9M
  • LUNG 106.3M
  • IPO Year
  • LHSW 2025
  • LUNG 2020
  • Fundamental
  • Price
  • LHSW $2.66
  • LUNG $1.84
  • Analyst Decision
  • LHSW
  • LUNG Buy
  • Analyst Count
  • LHSW 0
  • LUNG 6
  • Target Price
  • LHSW N/A
  • LUNG $11.53
  • AVG Volume (30 Days)
  • LHSW 202.7K
  • LUNG 418.6K
  • Earning Date
  • LHSW 01-01-0001
  • LUNG 07-30-2025
  • Dividend Yield
  • LHSW N/A
  • LUNG N/A
  • EPS Growth
  • LHSW N/A
  • LUNG N/A
  • EPS
  • LHSW 0.05
  • LUNG N/A
  • Revenue
  • LHSW $36,718,017.00
  • LUNG $87,473,000.00
  • Revenue This Year
  • LHSW N/A
  • LUNG $18.02
  • Revenue Next Year
  • LHSW N/A
  • LUNG $18.17
  • P/E Ratio
  • LHSW $54.32
  • LUNG N/A
  • Revenue Growth
  • LHSW 24.85
  • LUNG 19.84
  • 52 Week Low
  • LHSW $0.99
  • LUNG $2.50
  • 52 Week High
  • LHSW $8.18
  • LUNG $9.37
  • Technical
  • Relative Strength Index (RSI)
  • LHSW N/A
  • LUNG 31.51
  • Support Level
  • LHSW N/A
  • LUNG $3.03
  • Resistance Level
  • LHSW N/A
  • LUNG $3.39
  • Average True Range (ATR)
  • LHSW 0.00
  • LUNG 0.34
  • MACD
  • LHSW 0.00
  • LUNG -0.05
  • Stochastic Oscillator
  • LHSW 0.00
  • LUNG 9.86

About LHSW LIANHE SOWELL INTERNATIONAL GROUP L

Lianhe Sowell International Group Ltd is a holding company and operates its business through its subsidiary. It is a provider of machine vision products and solutions in China that invent and integrate technologies and solutions that address some of the most critical manufacturing and distribution challenges, such as precision and accuracy required in manufacturing of electronic products. The company categorize machine vision products in four categories based on their application settings: Industrial Machine Vision, Artificial Intelligence (Face Recognition and AI Behavior Analysis), Intelligent Weak Current (Building Intelligence and Intelligent Transportation) and Electronic Customs Clearance.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: